-
Leadgene Glycerol-Free Products - The Ideal Materials for Your POCT Development!
Leadgene's glycerol-free series products provides flexibility for various conditions and are compatible with LEADSPHERE™ Lyophilization Technology.
-
Quality RUO-Grade Biosimilar Antibodies Are Now Available at Leadgene
Leadgene offers about two hundreds RUO-grade biosimilar antibodies.
-
SARS-CoV-2 (COVID-19) Omicron Variant Mutation Sites in Spike Protein
The Omicron differs structurally from all other variants that have been known, and compared to the wild-type Wuhan-Hu-1 strain, 32 out of 50 mutations are located on the spike protein.
-
Does Omicron Variant Cause Milder Symptoms?
Multiple research teams recently proposed another unique feature of the Omicron: the variant prefers entering cells by an endosomal route, similar to SARS-CoV, rather than driving receptor-dependent syncytium formation, catalyzed by surface TMPRSS2 protease.
-
New Choices for Your RT-qPCR and Isothermal PCR Experiments!
Compatible with Leadsphere® Lyophilization Technology for a lyophilized format (glycerol-free)
-
Biomolecular Interaction/Kinetic Measurement
It is imperative to explore and develop more efficient and comprehensive methods to further improve drug development processes and address the challenges posed by increasingly complex diseases.
-
The War in Immunotherapy: Current Advances in DC-CIK Therapy Against Cancer
During the past few decades, numerous efforts have been devoted to the field of immunotherapy to improve the efficacy and safety of conventional therapies, such as radiation and chemotherapy.
-
Cross-Reactivity Between SARS-CoV-2 S1-RBD and ACE2 Was Found in the Sera of COVID-19 Patients
A study carried out by Leadgene Biomedical first identified the antibodies against ACE2 in COVID-19 patients, and then found a positive correlation between the amounts of antibodies against ACE2 and S1-RBD.
-
The Right Tool for the Right Job!
Let Leadgene Biomedical’s COVID-19 series products become your comprehensive solutions!
-
Hydrogel Technology Improves the Treatment of CAR-T Cell Therapy on Solid Tumors!
The scientists reported a new approach that utilizes injectable hydrogels to deliver CAR-T cells together with cytokines.